Ortin Laboratories Limited is engaged in manufacturing and trading of pharmaceuticals, drugs and intermediates. The Company's products include (2S)-3-Methyl-2-(methyl-2(methyl- ((2-(1-methyl ethyl)thiazole-4-yl)methyl) carbonyl)amino) butanoic acid (MTV); 2-(Chloro Methoxy)3, 4-Dimethoxy Pyridine Hydro Chloride, and (s)-5-chloro-alfa (cyclo Propyl ethnyl)-2- (4-methoxy phenyl)methyl)amino)-a- (trifluoro methyl) benzene methanol. It manufactures a range of pharmaceutical formulations of tablets, capsules, syrups and dry powders. Its formulations include Anti Diabetics, Anti Allergics, Anti Anginal & Cardio Vascular, Analgesics & Antipyretics, and Anti Biotics-Quinolones. Its active pharmaceutical ingredient (API) intermediates include Anti retro viral, Anti Diabetics, Ciprofloxacin, Tramadol and Efavarenz. It provides services in the area of process development, process characterization, analytical research and development, assay development and product characterization.